Light Chain Deposition Disease
IRB #H-25876/LCDD: High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT) in Immunoglobulin Deposition Disease or Light-Chain Deposition Disease (LCDD)
IRB #Pend/Merck V212: A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous
Hematopoietic Cell Transplants (HCTs) (pending)
